Lagundi, a plant commonly found in the Philippines. is set to be used in clinical trials for patients with COVID-19 at the University of the Philippines-Philippine General Hospital (UP-PGH).

The Lagundi clinical trials have been approved by the UP-PGH ethics committee and will await clearance from the Food and Drug Administration (FDA).

Department of Science and Technology (DOST) Secretary Fortunato de la Peña announced during his public briefing on July 17, 2020, that the agency had already approved funding for the clinical trials.